Janssen Pharmaceuticals’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

Janssen Pharmaceuticals manufactures and markets prescription pharmaceutical products. Read more

Janssen Pharmaceuticals manufactures and markets prescription pharmaceutical products. Read more

CEO Avatar


Michael Yang

CEO Approval Rating





Est. Annual Revenue
Est. Employees

Update Industry









Missing a competitor? Contribute!

BMS is the biggest rival of Janssen Pharmaceuticals. BMS was founded in 1858, and its headquarters is in New York, New York. BMS operates in the Pharmaceuticals industry. BMS has 29,850 more employees than Janssen Pharmaceuticals.

Crucell has been one of Janssen Pharmaceuticals's top competitors. Crucell is a Private company that was founded in Leiden, Other in 1993. Crucell competes in the Pharmaceuticals industry. Crucell has 200 more employees vs. Janssen Pharmaceuticals.

Novartis is Janssen Pharmaceuticals's #3 rival. Novartis was founded in 1996 in Basel, Basel-City. Novartis is in the Pharmaceuticals industry. Novartis generates $48.2B more revenue than Janssen Pharmaceuticals.


Help the Owler community know more

Competitor - 1/1

Is Merck a competitor of Janssen Pharmaceuticals?


No recent acquisitions found related to Janssen Pharmaceuticals








Alector develops and commercializes antibody therapeutics for the treatment of cancer and neurodegenerative diseases.
Mar 09, 2014
Series B
Feb 06, 2019

Janssen Pharmaceuticals News

July 8, 2020Pharmaceutical Processing World

J&J to pay Emergent BioSolutions an initial $480m to make COVID-19 vaccine

Emergent BioSolutions announced a five-year manufacturing agreement with Johnson & Johnson's (NYSE:JN... See more »
July 6, 2020PharmaTech

Emergent and Johnson & Johnson Enter into $480 Million Manufacturing Agreement for COVID-19 Vaccine

Emergent BioSolutions announced on July 6, 2020 that it is entering into a five-year, $480 million ma... See more »
June 17, 2020Homeland Preparedness News

Janssen Pharmaceuticals accelerates timeline for development of COVID-19 vaccine

Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, has accelerated the initiation of the Pha... See more »
June 15, 2020FinanzNachrichten

Long-term Trial Shows TREMFYA As Efficacious Therapy In Plaque Psoriasis

NEW BRUNSWICK (dpa-AFX) - Janssen Pharmaceutical Companies of Johnson & Johnson (JNJ) announced Monda... See more »
April 30, 2020Medical Buyer

Alveo Technologies Announces Research Collaboration With Janssen Pharmaceuticals, Inc. To Advance At-Home Testing Platform For Viral Infectious Diseases

Alveo Technologies, a leader in developing novel technologies that enable real-time, low-cost, at-hom... See more »
February 14, 2020BioPortfolio

Janssen's Stelara Sees Positive Results in Crohn's Disease Study httpdlvr.itRQ3Fg3Âpic.twitter.com2k0nnJheeG

Janssen's Stelara Sees Positive Results in Crohn's Disease Study httpdlvr.itRQ3Fg3 pic.twitter.com2k0... See more »

Janssen Pharmaceuticals Press Releases

April 17, 2018PRWeb

BioPlus Specialty Pharmacy Now Dispensing New Prostate Cancer Medication Erleada

BioPlus Specialty Pharmacy, one of the nation's leading innovative specialty pharmacies, can dispense... See more »
January 2, 2018ForImmediateRelease

Lawsuits Filed Against J&J Related to its Drug Invokana

Travel & Tourism Industry release: PORT WASHINGTON, N.Y., Jan. 2, 2018 /PRNewswire/ - Parker Waichman... See more »
September 26, 2017PR Newswire

Janssen Announces HealtheVoices Impact Fund Recipients

TITUSVILLE, N.J., Sept. 26, 2017 /PRNewswire/ -- Janssen Pharmaceuticals, Inc. today announced the re... See more »
August 14, 2017Blackbird

Cerecor Announces Divestiture of CERC-501 to Janssen Pharmaceuticals, Inc.

BALTIMORE, MD-(Marketwired - August 14, 2017) - Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical comp... See more »
June 22, 2017Blackbird

Parties to Pennsylvania Risperdal Gynecomastia Lawsuits Set to Meet Next Month to Discuss Status of Mass Tort Litigation, Bernstein Liebhard LLP Reports

NEW YORK, June 23, 2017 /PRNewswire/ -- Thousands of Risperdal lawsuits involving the antipsychotic m... See more »
June 14, 2017Newswise

UC San Diego Partners with Janssen to Research New Approaches to Treat Metabolic Diseases

University of California San Diego School of Medicine has entered a five-year strategic partnership w... See more »


PO Box 200 P.O. Box 200

Titusville, New Jersey08560


Driving Directions »

Trending Companies




Janssen Pharmaceuticals manufactures and markets prescription pharmaceutical products. Janssen Pharmaceuticals was founded in 06/1973. Janssen Pharmaceuticals' headquarters is located in Titusville, New Jersey, USA 08560. Janssen Pharmaceuticals' Pre...


Janssen Pharmaceuticals's President, Michael Yang, currently has an approval rating of 47%. Janssen Pharmaceuticals's primary competitors are BMS, Crucell & Novartis.



Frequently Asked Questions about Janssen Pharmaceuticals

  1. When was Janssen Pharmaceuticals founded?

    Janssen Pharmaceuticals was founded in 06/1973
  2. Who is Janssen Pharmaceuticals's CEO?

    Janssen Pharmaceuticals's CEO is Michael Yang
  3. How much revenue does Janssen Pharmaceuticals generate?

    Janssen Pharmaceuticals generates $34.5M in revenue
  4. How much funding does Janssen Pharmaceuticals have?

    Janssen Pharmaceuticals has historically raised $0 in funding
  1. Where is Janssen Pharmaceuticals's headquarters?

    Janssen Pharmaceuticals's headquarters is in Titusville New Jersey, USA
  2. How many employees does Janssen Pharmaceuticals have?

    Janssen Pharmaceuticals has 150 employees
  3. Who are Janssen Pharmaceuticals's competitors?

    Janssen Pharmaceuticals's top competitors are BMS, Crucell, Novartis
  4. Who has Janssen Pharmaceuticals invested in?

    Janssen Pharmaceuticals's has invested in companies such as Alector